Leukoplakia of the maxillary vestibule - An association with Viadent?

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 87, Issue 1, 1999, Pages 61-66

  Damm, Douglas D ^a   Curran, Alice ^b   White, Dean K ^c   Drummond, James F ^b   Lexington, Ky ^a   Jackson, Miss ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; BENZOPHENANTHRIDINE DERIVATIVE; ISOQUINOLINE DERIVATIVE; SANGUINARINE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; HUMAN; LEUKOPLAKIA; MALE; MAXILLA; MIDDLE AGED; MOUTH HYGIENE; MOUTH MUCOSA; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALKALOIDS; BENZOPHENANTHRIDINES; FEMALE; HUMANS; ISOQUINOLINES; LEUKOPLAKIA, ORAL; MALE; MAXILLA; MIDDLE AGED; MOUTH MUCOSA; MOUTHWASHES; RETROSPECTIVE STUDIES;

EID: 0032609275     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(99)70296-9     Document Type: Article

References (17)

1. Harkrader RJ, Reinhart PC, Rogers JA, Jones RR, Wylie RE II, Lowe BK, et al. The history, chemistry and pharmacokinetics of Sanguinaria extract. J Can Dent Assoc 1990;56(7 Suppl):7-12.
2. Kuftinec MM. Mueller-Joseph LJ, Kopczyk RA. Sanguinaria loothpaste and oral rinse regimen clinical efficacy in short- and long-term trials. J Can Dent Assoc 1990;(7 Suppl):31-3.
3. Frankos VH, Brusick DJ, Johnson EM, Maibach HI, Munro I, Squire RA, et al. Safety of Sanguinaria extract as used in commercial toothpaste and oral rinse products. J Can Dent Assoc 1990;56(7 Suppl)41-7.
4. Hakim SAE. Sanguinarine - a carcinogenic contaminant in Indian edible oils. Indian J Cancer 1968;10:183-97.
5. Schwartz HG. Safety profile of sanguinarine and sanguinaria extract. Compend Contin Educ Dent 1986;Suppl 7:S212-S217.
6. Das M, Khanna SK. Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol 1997;27:273-97.
7. Sarkar SN. Isolation from argemone oil of dihydrosanguinarine and sanguinarine: toxicity of sanguarine. Nature 1948;162:265-6.
8. Elvin-Lewis M, Lewis WH. New concepts in medical and dental ethanobotany. In: Schultes RE, von Reis S, editors. Ethanobotany: evolution of a discipline. Portland: Cioscorides Press; 1995, p. 303-10.
9. Saran A, Srivastava S, Coutinho E, Maiti M. 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J Biochem Biophys 1995;32:74-7.
10. Farnsworth NR, Bingel AS, Fong HH, Saleh AA, Christenson GM, Saufferer SM. Oncogenic and tumor-promoting spermatophytes and pteridophytes and their active principles. Cancer Treat Rep 1976;60:1171-214.
11. Upreti KK, Das M, Kumar A, Singh GB, Khanna SK. Biochemical toxicology of argemone oil: short-term oral feeding response in rats. Toxicology 1989;58:285-98.
12. Tandon S, Das M, Khanna SK. Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. Drug Metab Dispos 1993;21:194-7.
13. Hakim SAE, Mijovik V, Walker J. Experimental transmission of sanguinarine in milk: detection of a metabolic product. Nature 1961;189:201-4.
14. Maiti M, Nandi R, Chaudhuri K. Interaction of sanguinarine with natural and synthetic deoxyribonucleic acids. Indian J Biochem Biophys 1984;21:158-65.
15. Sen A, Ray A, Maiti M. Thermodynamics of the interaction of sanguinarine with DNA: influence of ionic strength and base composition. Biophys Chem 1996;59:155-70.
16. Weatherell JA, Robinson C, Rathbone MJ. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker; 1996. p. 157-69.
17. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. Philadelphia: WB Saunders; 1995. p. 287.